Some days, I watch my mother try to stand, and my breath catches. The doctors have warned us about bone weakness — how…
Myeloma
For seven years, I have kept up on developments in multiple myeloma research. I follow the latest treatments, the newest studies, and…
The U.S. Food and Drug Administration (FDA) has approved a new version of Sarclisa (isatuximab), an approved treatment for multiple myeloma sold by…
Regulatory authorities in two countries have given the green light for clinical testing of a novel treatment from Mabwell Bioscience — which the company…
I find myself watching my mother’s hands more often these days. It shouldn’t come as a surprise, though. After all, observation is one of…
A protein called IRF2 may help drive myeloma, and measuring its levels could help predict outcomes among people with the blood cancer, a new…
Some nights I sit beside my mum’s bed and look back on the four years since her myeloma diagnosis. I find it hard to…
U.S. authorities have granted a permanent billing code for Blenrep (belantamab mafodotin), an approved treatment for certain adults with hard-to-treat multiple myeloma., a…
A regulatory committee in the European Union has recommended expanding approval of a dual regimen for hard-to-treat myeloma —…
Note: This column describes the author’s own thoughts about GLP-1 agonist medications. Not everyone will have the same response to treatment. Consult your doctor before…
Recent Posts
- Infection risk shifts over time with both CAR T and bispecific antibody therapy
- Building the quiet architecture of a caregiving day
- New CAR T-cell therapy shows promise in tough myeloma cases
- CAR T-cell therapy before surgery boosts glioblastoma control in mice
- Gynecologic Cancer Awareness Month urges education, action, and support